Related Experiment Videos

[Can acute disseminated encephalomyelitis progress in a deferred way?]

B Gener1, C Garaizar-Axpe, C Ruiz Espinosa

  • 1Hospital de Cruces, Baracaldo, 48903, España.

Revista De Neurologia
|September 20, 2001
PubMed
Abstract

Insights

Acute disseminated encephalomyelitis (ADEM) can present with recurrent symptoms, suggesting a multiphasic course. This case highlights favorable outcomes with combined methylprednisolone and immunoglobulin therapy for recurrent ADEM.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Immunology

Background:

  • Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinating disease.
  • ADEM typically presents as a monophasic illness, but heterogeneous clinical courses are increasingly recognized.
  • Differentiating recurrent ADEM from other demyelinating conditions like multiple sclerosis (MS) is crucial for appropriate management.

Observation:

  • A 5-year-old boy experienced two distinct episodes of neurological symptoms separated by several weeks.
  • Clinical presentation and magnetic resonance imaging (MRI) findings were consistent with ADEM.
  • Cerebrospinal fluid (CSF) analysis showed no oligoclonal bands, aiding in the exclusion of multiple sclerosis (MS).

Findings:

  • The recurrent neurological symptoms in this pediatric patient suggest a multiphasic disseminated encephalomyelitis (MDEM).
  • The case demonstrates that ADEM can exhibit a multiphasic or relapsing-remitting course.
  • Exclusion of MS was based on clinical course, MRI, and CSF findings.

Implications:

  • Recognition of MDEM is important for accurate diagnosis and prognosis in pediatric demyelinating diseases.
  • Prompt and aggressive treatment, including corticosteroids and immunoglobulins, may lead to favorable outcomes in MDEM.
  • This case underscores the importance of considering multiphasic presentations of ADEM in children.

Related Concept Videos